Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Wave Life Sciences
WVE
$1.09B
| $68.6K | ﹤0.01% |
18,837
-12,485
| -40% | -$50.4K |
|
|
JMIA
3552
Jumia Technologies
JMIA
$737M
| $68.4K | ﹤0.01% |
20,000
+7,500
| +60% | +$23K |
|
|
OGI
3553
Organigram Holdings
OGI
$132M
| $67.9K | ﹤0.01% |
10,875
+1,000
| +10% | +$1.93K |
|
3554
Heron Therapeutics
HRTX
$93.9M
| $66.4K | ﹤0.01% |
57,233
-41,700
| -42% | -$74.4K |
|
|
ESSA
3555
DELISTED
ESSA Bancorp
ESSA
| $66.3K | ﹤0.01% |
4,438
+1,745
| +65% | +$26.3K |
|
3556
Kaltura
KLTR
$206M
| $65.8K | ﹤0.01% |
31,059
+20,261
| +188% | +$37.6K |
|
3557
Cabaletta Bio
CABA
$437M
| $65.8K | ﹤0.01% |
5,096
-62,102
| -92% | -$674K |
|
3558
iShares MSCI Thailand ETF
THD
$369M
| $65.8K | ﹤0.01% |
1,000
| – | – |
|
3559
Motley Fool 100 Index ETF
TMFC
$2.05B
| $65.4K | ﹤0.01% |
1,606
| – | – |
|
3560
Esquire Financial Holdings
ESQ
$1.12B
| $65.2K | ﹤0.01% |
1,425
-2,124
| -60% | -$87.1K |
|
3561
Janux Therapeutics
JANX
$925M
| $65K | ﹤0.01% |
5,479
-3,425
| -38% | -$45.8K |
|
|
ALPN
3562
DELISTED
Alpine Immune Sciences Inc
ALPN
| $65K | ﹤0.01% |
6,325
-5,754
| -48% | -$51.9K |
|
3563
Core Molding Technologies
CMT
$202M
| $65K | ﹤0.01% |
2,858
-3,675
| -56% | -$71.3K |
|
3564
Comscore
SCOR
$106M
| $65K | ﹤0.01% |
4,011
| – | – |
|
|
NEXN
3565
Nexxen International
NEXN
$573M
| $64.8K | ﹤0.01% |
9,000
| – | – |
|
3566
Citizens Financial Services
CZFS
$373M
| $64.6K | ﹤0.01% |
884
-331
| -27% | -$26.9K |
|
3567
Seer Inc
SEER
$122M
| $64.5K | ﹤0.01% |
15,110
-26,487
| -64% | -$104K |
|
|
MGIC
3568
DELISTED
Magic Software Enterprises
MGIC
| $64.5K | ﹤0.01% |
+4,850
| New | +$64.2K |
|
3569
Vanguard Morningstar Growth ETF
VUG
$220B
| $64.2K | ﹤0.01% |
+1,362
| New | +$59.1K |
|
3570
Northeast Bank
NBN
$1.06B
| $64.1K | ﹤0.01% |
1,539
-1,779
| -54% | -$67.5K |
|
3571
Invesco S&P SmallCap Low Volatility ETF
XSLV
$248M
| $64.1K | ﹤0.01% |
+1,610
| New | +$65.1K |
|
3572
iHeartMedia
IHRT
$543M
| $63.9K | ﹤0.01% |
17,568
+15,313
| +679% | +$50.9K |
|
3573
EverCommerce
EVCM
$2.18B
| $63.9K | ﹤0.01% |
5,395
-6,672
| -55% | -$78K |
|
3574
Utah Medical Products
UTMD
$225M
| $63.8K | ﹤0.01% |
685
-1,065
| -61% | -$100K |
|
3575
Inspired Entertainment
INSE
$184M
| $63.7K | ﹤0.01% |
4,329
-6,441
| -60% | -$87.2K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.